Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-16 4:32 pm Purchase | 2021-12-06 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Montanova Capital, LLC | 102,840 5.200% | 102,840 (New Position) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | SUTRO BIOPHARMA INC STRO | Montanova Capital, LLC | 240,840 5.200% | 240,840 (New Position) | Filing History |
| 2021-12-09 4:31 pm Purchase | 2021-11-29 | 13G | KURA ONCOLOGY INC KURA | Montanova Capital, LLC | 3,503,419 5.300% | 3,503,419 (New Position) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Montanova Capital, LLC | 111,513 6.000% | 111,513 (New Position) | Filing History |
| 2021-10-15 4:49 pm Purchase | 2021-10-05 | 13G | GEMINI THERAPEUTICS INC GMTX | Montanova Capital, LLC | 223,284 5.200% | 133,338 (+148.24%) | Filing History |
| 2021-09-17 4:54 pm Purchase | 2021-09-07 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Montanova Capital, LLC | 1,296,452 5.300% | 1,296,452 (New Position) | Filing History |